Literature DB >> 22825250

Alterations of polycomb gene BMI1 in human myeloproliferative neoplasms.

Mandy Brecqueville, José Adélaïde, François Bertucci, Pascal Finetti, Max Chaffanet, Daniel Birnbaum, Anne Murati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22825250      PMCID： PMC3442924          DOI： 10.4161/cc.21114

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

1.  Tumor suppressor function of the polycomb group genes.

Authors:  Makiko Mochizuki-Kashio; George R Wendt; Atsushi Iwama
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 2.  Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Authors:  Adrian P Bracken; Kristian Helin
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

3.  Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.

Authors:  Joannah Score; Claire Hidalgo-Curtis; Amy V Jones; Nils Winkelmann; Alison Skinner; Daniel Ward; Katerina Zoi; Thomas Ernst; Frank Stegelmann; Konstanze Döhner; Andrew Chase; Nicholas C P Cross
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

4.  Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.

Authors:  Thomas Ernst; Andrew J Chase; Joannah Score; Claire E Hidalgo-Curtis; Catherine Bryant; Amy V Jones; Katherine Waghorn; Katerina Zoi; Fiona M Ross; Andreas Reiter; Andreas Hochhaus; Hans G Drexler; Andrew Duncombe; Francisco Cervantes; David Oscier; Jacqueline Boultwood; Francis H Grand; Nicholas C P Cross
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

5.  Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Authors:  Gorica Nikoloski; Saskia M C Langemeijer; Roland P Kuiper; Ruth Knops; Marion Massop; Evelyn R L T M Tönnissen; Adrian van der Heijden; Theresia N Scheele; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

6.  Rearrangements involving 12q in myeloproliferative disorders: possible role of HMGA2 and SOCS2 genes.

Authors:  Anne Etienne; Nadine Carbuccia; José Adélaïde; Ismahane Bekhouche; Virginie Rémy; Claudine Sohn; Danielle Sainty; Jean-Albert Gastaut; Sylviane Olschwang; Daniel Birnbaum; Marie-Joëlle Mozziconacci; Max Chaffanet
Journal:  Cancer Genet Cytogenet       Date:  2007-07-01

7.  Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms.

Authors:  M Brecqueville; N Cervera; J Adélaïde; J Rey; N Carbuccia; M Chaffanet; M J Mozziconacci; N Vey; D Birnbaum; V Gelsi-Boyer; A Murati
Journal:  Blood Cancer J       Date:  2011-08-26       Impact factor: 11.037

8.  Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice.

Authors:  Hideyuki Oguro; Atsushi Iwama; Yohei Morita; Takehiko Kamijo; Maarten van Lohuizen; Hiromitsu Nakauchi
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

9.  ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

Authors:  Omar Abdel-Wahab; Mazhar Adli; Lindsay M LaFave; Jie Gao; Todd Hricik; Alan H Shih; Suveg Pandey; Jay P Patel; Young Rock Chung; Richard Koche; Fabiana Perna; Xinyang Zhao; Jordan E Taylor; Christopher Y Park; Martin Carroll; Ari Melnick; Stephen D Nimer; Jacob D Jaffe; Iannis Aifantis; Bradley E Bernstein; Ross L Levine
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

10.  Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.

Authors:  Véronique Gelsi-Boyer; Virginie Trouplin; José Adélaïde; Nicola Aceto; Virginie Remy; Stephane Pinson; Claude Houdayer; Christine Arnoulet; Danielle Sainty; Mohamed Bentires-Alj; Sylviane Olschwang; Norbert Vey; Marie-Joëlle Mozziconacci; Daniel Birnbaum; Max Chaffanet
Journal:  BMC Cancer       Date:  2008-10-16       Impact factor: 4.430
View more
  4 in total

1.  Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase.

Authors:  Mandy Brecqueville; Jérôme Rey; Raynier Devillier; Arnaud Guille; Rémi Gillet; José Adélaide; Véronique Gelsi-Boyer; Christine Arnoulet; Max Chaffanet; Marie-Joelle Mozziconacci; Norbert Vey; Daniel Birnbaum; Anne Murati
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

Review 2.  Myeloid malignancies: mutations, models and management.

Authors:  Anne Murati; Mandy Brecqueville; Raynier Devillier; Marie-Joelle Mozziconacci; Véronique Gelsi-Boyer; Daniel Birnbaum
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

Review 3.  BMI1: A Biomarker of Hematologic Malignancies.

Authors:  Anagh A Sahasrabuddhe
Journal:  Biomark Cancer       Date:  2016-05-05

Review 4.  Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis.

Authors:  Christophe Desterke; Christophe Martinaud; Nadira Ruzehaji; Marie-Caroline Le Bousse-Kerdilès
Journal:  Mediators Inflamm       Date:  2015-11-12       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.